As of November 2024, Emergent BioSolutions has a market cap of $358.00M. This makes Emergent BioSolutions the world's 13559th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $85.87M | -31.04% |
2023 | $124.52M | -79.68% |
2022 | $612.75M | -72.83% |
2021 | $2.26B | -51.48% |
2020 | $4.65B | 66.08% |
2019 | $2.80B | -8.99% |
2018 | $3.08B | 27.57% |
2017 | $2.41B | 41.50% |
2016 | $1.70B | -17.92% |
2015 | $2.08B | 46.93% |
2014 | $1.41B | 18.44% |
2013 | $1.19B | 43.33% |
2012 | $832.23M | -4.75% |
2011 | $873.73M | -28.22% |
2010 | $1.22B | 72.63% |
2009 | $705.11M | -47.95% |
2008 | $1.35B | 416.01% |
2007 | $262.54M | -54.66% |
2006 | $579.03M | - |